Skip to main content

Home/ Dr. Goodyear/ Group items tagged low-dose chemotherapy

Rss Feed Group items tagged

Nathan Goodyear

Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with meta... - 0 views

  •  
    IV vitamin C shown to be adjunctive with the chemotherapy regimens FOLFIRI and FOLFOX in colorectal and gastric cancer despite the therapeutic dose limited to 1.5 mg/kg/day, which is a low dose likely resulting in sub-therapeutic levels.
Nathan Goodyear

A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melat... - 1 views

  •  
    Average progression-free time and percentage of patients alive at 1 year was significantly higher in those using IL-2 and melatonin compared to chemotherapy in aggressive NSCLC. Of note, in this study, they used a repeat cycle of IL-2 and MLT as well as a once/week maintenance IL-2 and MLT.
Nathan Goodyear

Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid... - 0 views

  •  
    Metronomic chemotherapy reduces MDSCs recruitment.
Nathan Goodyear

Metronomic Chemotherapy in Non-Small-Cell Lung Cancer | Request PDF - 0 views

  •  
    LDMC effect in lung cancer via its Antiangiogenic and anti immunosuppressive effects.
Nathan Goodyear

ChemoImmunoModulation: Immune Regulation by the Antineoplastic Chemotherapeutic Agents ... - 0 views

  •  
    Chemoimmunomodulation: get to know it.
« First ‹ Previous 41 - 60 of 145 Next › Last »
Showing 20 items per page